HB 140, the Ron Silverio/Heather Block End of Life Options Act, introduced by Delaware State Representative Paul Baumbach (D-23), was heard in a House committee.
- HB 140
- Introduced on May 2, 2019.
- Sponsors: Delaware State Representatives Paul S. Baumbach (D) (primary sponsor), Representative Edward S. Osienski (D), Gerald L. Brady (D), John A. Kowalko (D), and Raymond Seigfried (D), and Delaware State Senators David P. Sokola (D) and Stephanie L. Hansen (D).
- Referred to the House Health and Human Development Committee.
- A public hearing took place on May 8, with the Committee taking no action on the bill.
Write your Delaware State Legislators to urge their support for HB 140, the End of Life Options Act
The Delaware General Assembly is again considering a death with dignity bill. HB 140, Ron Silverio/Heather Block End of Life Options Act, will allow qualified adult residents of Delaware with a terminal illness to legally obtain a prescription from their physician for medications to end their life peacefully, in a dignified way, at the place and time of their choosing.
Representative Paul Baumbach and 3 co-sponsors, Representative Bryon Short (D-7), Senator David Sokola (D-8), and Senator Margaret Henry (D-2) introduced HB 160, End of Life Options Act, on May 2, 2017. The bill was assigned to the House Health and Human Development Committee, which voted to send it to the full House for a vote (the vote was 1 in favor, 5 on its merits, i.e. the legislators neither supported nor opposed the bill but believed it should get a House floor vote, and 2 opposed. The bill was amended on June 28. No further action occurred in 2017.
The bill was rolled over to 2018. After another amendment, the vote in the House was delayed twice, and the bill did not advance.
In 2015, Representative Paul Baumbach sponsored HB 150, which was tabled in Committee.
While the bill did not have enough support to move forward, another bill in the same session related to end-of-life options did become law: HB 64, Delaware Medical Orders for Scope of Treatment Act, established a different end-of-life option.